viral
infect
affect
human
health
throughout
histori
difficult
long
expens
race
bring
new
drug
market
convolut
appear
new
viral
diseas
rapidli
spread
around
world
among
recent
emerg
viral
pathogen
chikungunya
middl
east
respiratori
syndrom
zika
mention
great
concern
world
health
organ
exampl
recent
spike
zika
viru
infect
sever
state
brazil
health
offici
scrambl
understand
specif
aspect
viru
vaccin
develop
way
viru
crossreact
antibodi
antibodydepend
enhanc
need
thu
part
effort
scientif
commun
allevi
pain
exist
emerg
epidem
new
improv
way
studi
viral
process
understand
advers
effect
host
need
intric
cross
talk
viru
host
evidenc
inabl
phenotypicbas
approach
antivir
discoveri
least
first
identifi
specif
step
target
affect
focus
discret
step
viral
life
cycl
attach
entri
decoat
replic
viral
genom
matur
bud
infecti
viral
particl
facilit
pinpoint
method
drug
discoveri
approach
lead
target
discoveri
ifwhen
specif
drug
target
viralhost
process
known
jonsson
et
exampl
util
realtim
pcr
identifi
relationship
enterovirus
host
cell
receptor
bind
attempt
establish
improv
method
understand
specif
interact
viru
host
addit
lundin
et
identifi
inhibitor
specif
target
membranebound
rna
synthesi
certain
coronavirus
includ
middl
east
respiratori
syndrom
event
life
cycl
potenti
serv
target
antivir
basic
mechan
understood
factor
involv
known
focu
proteolysi
critic
step
cross
talk
viru
host
potenti
yet
unmet
capabl
drug
discoveri
histor
viralencod
proteas
exist
obviou
target
antivir
array
proteas
inhibitor
pi
market
human
immunodefici
viru
proteas
sake
simplic
proteas
refer
pr
recent
hepat
c
viru
hcv
exemplifi
fact
howev
proteolysi
context
viral
infect
much
complex
process
defin
cleavag
viral
host
protein
either
viralencod
proteas
hostencod
member
flavivirida
hcv
dengu
viru
denv
repres
good
exampl
viral
proteom
embed
endoplasm
reticulum
er
membran
cleav
viralencod
proteas
site
face
cytosol
host
peptidas
peptid
peptidas
protein
convertas
mainli
furin
membranouslumin
viralencod
proteas
obviou
target
develop
inhibitor
hostencod
proteas
specif
act
viral
proteom
fulli
met
potenti
candid
develop
competitor
understand
viral
life
cycl
discret
step
requir
target
discoveri
furthermor
take
consider
specif
locat
cell
step
occur
enhanc
power
target
drug
discoveri
ultim
lead
potent
effici
antivir
particularli
proteolysi
proteolyt
event
occur
variou
subcellular
monitor
cleavag
compart
elucid
cellular
requir
cleavag
natur
cellular
milieu
facilit
discoveri
biolog
relev
specif
antivir
would
therefor
effect
mind
previous
develop
assay
monitor
cleavag
activ
within
cytosol
environ
well
assay
monitor
cleavag
envelop
env
boundari
within
vesicl
classic
secretori
addit
assay
adapt
premembran
protein
denv
also
cleav
golgitransgolgi
network
use
pilot
demonstr
util
assay
drug
discoveri
shown
exploit
power
genet
engin
retrovir
technolog
combin
one
assay
increas
multiplex
capabl
enhanc
drug
discoveri
keep
specif
pr
one
bestcharacter
studi
viralencod
protein
driven
mostli
pandem
need
antivir
also
exemplifi
viral
protein
activ
within
cytosol
environ
viral
capsid
late
stage
viral
life
cycl
prior
post
hiv
caus
agent
aid
lentiviru
within
retrovirida
famili
virus
produc
dsdna
rna
genom
process
revers
transcript
process
notori
introduct
larg
number
mutat
due
lack
proofread
capabl
viralencod
revers
larg
number
mutat
lead
resist
strain
complic
success
vaccin
develop
highlight
continu
need
inhibitor
despit
exist
array
effect
viral
aspartyl
pr
respons
posttransl
cleavag
viral
proteom
cleav
one
also
known
possess
autocatalyt
properti
cleav
precursor
gagpol
polyprotein
two
molecul
dimer
process
rest
viral
host
enzym
furin
process
boundari
assay
previous
describ
monitor
pr
activ
reli
wellcharacter
yeast
transcript
factor
broadli
util
classic
twohybrid
system
regul
gene
express
assay
similar
twohybrid
system
exploit
ntermin
dnabind
domain
ctermin
transactiv
domain
howev
assay
pr
fuse
two
domain
pr
mutat
inhibit
activ
transcript
enhanc
green
fluoresc
protein
egfp
gene
downstream
upstream
activ
sequenc
ua
way
assay
easili
discrimin
activ
nonact
pr
base
fluoresc
engin
induc
manner
circumv
possibl
cytotox
effect
pr
express
mammalian
mention
protein
cleav
viral
pr
env
cleav
furin
vesicl
classic
secretori
pathway
primarili
golgi
classic
secretori
pathway
repres
essenti
system
posttransl
modif
transport
protein
cell
surfac
constitut
er
golgi
transgolgi
network
classic
secretori
pathway
hous
multitud
enzym
respons
posttransl
modif
includ
signal
peptidas
signal
peptid
peptidas
respons
cleav
signal
sequenc
er
clear
misfold
protein
matur
certain
viral
protein
infect
notabl
hcv
core
addit
famili
enzym
known
proprotein
convertas
respons
remov
inhibitori
domain
lead
activ
matur
certain
exampl
util
pathway
cleavagematur
viralencod
env
protein
en
rout
cell
surfac
translat
env
glycoprotein
transloc
er
posttransl
modifi
matur
activ
form
prototyp
proprotein
convertas
furin
process
absolut
requir
product
infecti
env
subunit
transport
cell
surfac
remain
noncoval
associ
incorpor
bud
viral
previous
describ
assay
design
specif
monitor
proteolyt
process
env
classic
secretori
pathway
assay
reli
doubletag
scaffold
fusion
protein
engin
local
er
travers
classic
secretori
pathway
en
rout
cell
surfac
cell
surfac
scaffold
embed
within
cell
membran
cleavag
boundari
lack
thereof
recogn
antibodi
stain
detect
classic
method
flow
cytometri
allow
us
discrimin
accur
robust
manner
cleav
uncleav
event
base
presenc
one
two
tag
year
multiplex
becom
attract
tool
biomed
applic
enhanc
power
analysi
combin
high
experiment
effici
decreas
cost
multiplex
proven
practic
method
vitro
studi
cellbas
defin
simultan
evalu
sever
experiment
element
multiplex
appli
wide
varieti
system
format
flow
specif
laboratori
success
combin
use
fluoresc
protein
genet
engin
retrovir
technolog
obtain
cell
line
order
gener
varieti
multiplex
format
furthermor
allow
us
ensur
stabl
nondeterior
express
differ
fluoresc
protein
differ
intens
util
format
demonstr
stolp
et
al
use
differ
cellbas
platform
genet
barcod
highthroughput
screen
show
addit
multiplex
capabl
combin
two
biolog
system
one
interrog
independ
process
one
monitor
cleavag
viralencod
proteas
accur
detect
cleavag
host
enzym
furin
addit
demonstr
use
genet
barcod
highthroughput
screen
ht
applic
robust
reliabl
associ
techniqu
highlight
import
select
clonal
popul
stabli
express
assay
also
compar
mixtur
cell
popul
express
assay
popul
engin
cell
carri
two
assay
result
illustr
power
multiplex
genet
engin
retrovir
technolog
focus
proteolyt
cleavag
viru
andor
host
strategi
enhanc
abil
monitor
interact
broader
spectrum
virus
andor
protein
proteolyt
process
carri
differ
manner
variou
protein
evalu
eleg
rapid
manner
provid
valuabl
tool
research
learn
new
viral
behavior
well
understood
well
potenti
discov
novel
interact
yet
character
previous
shown
abil
robustli
accur
monitor
proteolyt
cleavag
pr
env
boundari
although
two
assay
base
fluoresc
differ
natur
first
reli
egfp
fluoresc
pr
inhibit
second
classic
fluoresc
label
antibodi
presenc
second
tag
cleavag
inhibit
fig
antibodi
stain
allow
flexibl
one
use
array
fluoresc
label
antibodi
primari
secondari
thu
investig
possibl
exploit
distinct
fluoresc
featur
two
assay
analyz
combin
purpos
util
allophycocyanin
apc
label
secondari
antibodi
ha
tag
second
assay
apc
emiss
spectrum
overlap
egfp
although
transfect
experi
use
high
level
protein
express
detect
transient
natur
lead
eventu
loss
express
gene
interest
rate
declin
depend
sever
key
factor
includ
protein
halflif
stabil
protein
rate
cell
divis
transfect
mani
year
retrovir
technolog
provid
solut
loss
gene
retrovir
technolog
fluorescenceactiv
cell
sort
fac
distinct
cell
popul
easili
amplifi
base
appropri
fluoresc
goal
ultim
obtain
cell
line
express
two
independ
assay
provid
robust
tool
screen
antivir
thu
critic
first
prove
assay
express
independ
test
conjunct
whether
mix
cell
cell
background
order
first
perform
transfect
experi
includ
necessari
element
assay
proceed
amplifi
select
sort
popul
goal
obtain
stabl
cell
line
express
engin
assay
proceed
first
assay
monitor
pr
much
complex
second
monitor
cleavag
env
reli
three
plasmid
rather
one
refer
materi
method
section
detail
cell
induc
doxycyclin
dox
analyz
inhibit
presenc
pi
darunavir
dar
observ
presenc
egfpposit
cell
expect
shown
figur
drastic
increas
egfpposit
cell
sever
round
flow
cytometri
analysi
compar
origin
cotransfect
experi
illustr
use
import
associ
engin
stabli
express
cell
line
particularli
intend
use
screen
andor
multiplex
applic
figur
show
individu
assay
depend
differ
fluorescencebas
detect
method
clearli
distinguish
individu
pr
assay
show
robust
shift
fluorescein
isothiocyan
fitc
channel
egfp
posit
follow
dar
treatment
top
panel
individu
env
assay
show
robust
shift
apc
channel
ha
posit
bottom
panel
importantli
combin
mix
equal
ratio
mix
popul
depict
expect
phenotyp
anticip
rate
approxim
mix
popul
treat
pi
dar
shift
approxim
half
popul
fitc
posit
observ
fig
green
window
similarli
stain
antiha
antibodi
shift
approxim
half
popul
apc
posit
observ
red
window
result
clearli
illustr
assay
distinguish
within
mix
popul
base
specif
treatment
stain
condit
requir
system
gate
fitc
posit
green
popul
apc
posit
red
popul
combin
yet
clearli
distinguish
fig
combin
sampl
mix
differenti
multipl
assay
readout
use
necessarili
special
remain
seen
cell
line
harbor
two
independ
assay
use
platform
one
assay
deconvolut
distinguish
therefor
proceed
establish
within
cell
two
biolog
system
previous
develop
individu
cell
purpos
cell
line
express
assay
pr
thu
element
necessari
rtta
uasegfp
report
fusion
transduc
retrovir
particl
carri
hivenv
assay
construct
figur
depict
flow
cytometri
analysi
cell
genet
engin
express
assay
first
panel
figur
show
neg
control
untreat
unstain
without
dox
follow
induct
dox
treatment
pi
dar
larg
percentag
cell
turn
posit
egfp
green
window
order
prove
cell
carri
env
assay
well
cell
stain
ha
antibodi
apccoupl
secondari
antibodi
corrobor
scaffold
protein
travel
cell
surfac
stain
haapc
larg
percentag
cell
turn
posit
ha
red
window
importantli
larg
percentag
popul
turn
posit
egfp
ha
doubleposit
popul
purpl
window
cell
stain
haapc
induc
treat
dar
order
demonstr
env
assay
monitor
env
clevag
cell
cell
treat
furin
inhibitor
decanoylrvkrchloromethylketon
dck
stain
flag
apccoupl
secondari
antibodi
fig
similar
singleposit
egfp
popul
green
window
appear
flagapcstain
cell
follow
dox
dar
treatment
importantli
similar
singleposit
red
window
doubleposit
popul
purpl
window
appear
follow
dck
treatment
clearli
demonstr
cell
robustli
express
assay
simultan
monitor
pr
activ
env
cleavag
result
prove
system
clearli
distinctli
monitor
base
treatment
requir
detect
cellbas
approach
increasingli
seen
valuabl
tool
molecular
biolog
drug
develop
becom
increasingli
obviou
better
robust
cellbas
assay
requir
phenotyp
drug
screen
particularli
target
screen
pain
path
drug
discoveri
emphas
need
pinpoint
cellbas
assay
interrog
specif
process
andor
target
earli
screen
stage
cellbas
platform
one
develop
critic
reliabl
tool
enhanc
earlystag
drug
discoveri
due
cellular
natur
provid
straightforward
approach
circumv
need
independ
addit
cytotox
test
drug
intak
cell
membran
thu
reduc
cost
time
critic
initi
stage
drug
discoveri
cellular
natur
also
provid
better
milieu
investig
biolog
process
interact
discern
factor
requir
full
activ
enzymat
function
investig
platform
establish
focus
proteolyt
cleavag
critic
set
process
intric
relationship
pathogen
host
requir
establish
viral
infect
part
platform
previous
develop
cellbas
assay
monitor
proteolyt
cleavag
viralencod
proteas
success
implement
pr
also
develop
assay
monitor
cleavag
within
classic
vesicl
classic
secretori
pathway
assay
engin
specif
monitor
cleavag
env
boundari
host
enzym
resid
golgitransgolgi
network
notabl
furin
exploit
power
cell
line
engin
enhanc
abil
studi
interact
target
approach
focus
proteolyt
cleavag
also
intend
strengthen
capabl
antivir
screen
creat
cell
line
demonstr
technolog
exploit
distinct
biolog
applic
long
reli
differ
readout
paramet
util
retrovir
technolog
genet
engin
show
dramat
increas
assay
robust
stabl
cell
line
compar
transient
express
experi
stabl
cell
line
drastic
increas
assay
sensit
thu
allow
improv
investig
effort
reliabl
highthroughout
drug
screen
addit
shown
power
combin
biolog
applic
monitortest
proteolyt
activ
cleavag
differ
viral
protein
possibl
due
differ
fluoresc
natur
individu
assay
assay
monitor
pr
activ
reli
egfp
assay
monitor
cleavag
env
reli
fluoresc
label
antibodi
stain
thu
use
fluoresc
channel
distinguish
fluoresc
channel
egfp
fitc
thu
test
whether
mix
cell
popul
harbor
respect
assay
could
still
distinct
display
specif
phenotyp
give
us
abil
monitor
activ
multipl
target
simultan
analysi
flow
cytometri
clearli
show
mix
popul
cell
test
follow
individu
treatment
induct
dox
treatment
pi
pr
assay
ha
stain
env
assay
inde
display
appropri
phenotyp
egfp
express
ha
surfac
express
respect
result
clearli
demonstr
differ
biolog
system
combin
provid
system
robust
enough
distinguish
counterpart
accur
readout
obtain
respect
assay
proceed
investig
whether
two
assay
still
distinguish
cell
background
rather
mix
cell
background
express
one
assay
order
combin
two
assay
addit
genet
engin
effort
requir
exploit
retrovir
technolog
express
env
assay
within
cell
line
origin
express
element
pr
assay
success
gener
stabl
cell
line
harbor
establish
assay
engin
cell
line
analyz
respect
system
without
need
accur
mix
two
distinct
popul
result
show
robust
readout
individu
assay
case
whether
cell
treat
pr
assay
ad
dox
pi
env
assay
stain
ha
importantli
ad
dox
pi
ha
stain
mix
experi
show
popul
kept
distinct
characterist
assay
gave
us
confid
proceed
engin
twoassaysonecel
system
multiplex
onecel
system
platform
repres
use
approach
determin
compound
specif
screen
inhibitor
variou
viral
target
shown
pr
env
furthermor
assay
function
intern
control
compound
specif
allow
select
target
screen
within
cellular
content
platform
serv
use
tool
target
drug
discoveri
allow
monitor
multipl
proteinstarget
viru
simultan
first
cellular
platform
type
stabli
express
two
distinct
assay
interrog
two
process
occur
two
differ
cellular
compart
hek
cell
plate
plate
cell
per
well
hour
prior
transfect
cell
cotransfect
ng
revers
tetracyclin
transactiv
ua
uasegfp
hiv
fusion
pr
use
highpot
polyethylenimin
pei
linear
mw
polysci
inc
dna
dilut
accord
manufactur
specif
cell
treat
dox
hiv
pr
inhibitor
dar
need
analyz
hour
posttransfect
via
flow
cytometri
phoenix
gp
cell
human
embryon
kidney
hek
cell
maintain
dulbecco
modifi
eagl
medium
dmem
cellgro
supplement
fetal
calf
serum
fc
mm
lglutamin
human
tcell
line
maintain
complet
roswel
park
memori
institut
medium
rpmi
cellgro
supplement
fc
mm
lglutamin
phoenix
gp
cell
provid
gari
nolan
stanford
univers
hek
cell
provid
chri
glembotski
san
diego
state
univers
cell
obtain
american
type
cultur
collect
atcc
antiflag
antibodi
obtain
sigmaaldrich
antiha
antimous
igg
alexa
antirabbit
alexa
fluor
obtain
cell
signal
dck
obtain
tocri
bioscienc
dissolv
dimethyl
sulfoxid
dox
obtain
sigmaaldrich
dar
nation
institut
health
bestesda
md
product
moloney
murin
leukemia
viru
mlv
base
retroviru
phoenix
gp
cell
line
confluenc
plate
transfect
transfer
vector
pbmnhiv
env
wtiblasticidin
vector
express
envelop
glycoprotein
vesicular
stomat
viru
pcivsvg
plasmid
mix
fcsfree
dmem
pei
per
dna
dmem
media
replac
hour
posttransfect
viral
supernat
collect
hour
transfect
viral
stock
filter
polyvinyliden
fluorid
pvdf
filter
olympu
manufactur
either
use
upon
collect
frozen
ml
aliquot
cell
grown
rpmi
cellswel
sixwel
plate
prepar
transduct
cell
treat
polybren
hexadimethrin
bromid
sigmaaldrich
transduc
viral
stock
hang
bucket
rotor
centrifug
becton
dickinson
g
minut
cell
analyz
express
hour
postinfect
flow
cytometri
facil
sdsu
perform
analysi
cell
bd
facsaria
nm
laser
well
bd
facscanto
use
blue
laser
red
laser
data
collect
use
facsdiva
softwar
analyz
flowjo
version
